As the entire world continues to fight the COVID-19 pandemic, new spikes in infection rates and hospitalizations have resulted in severe ongoing shortages of personal protective equipment (PPE) in medical facilities across the country. This forces health care professionals to ration equipment or improvise, which compromises their safety as well as that of the patients they treat.
Founded in 2020, Medicevo Corporation (Medicevo) has retained The Pollack Group (TPG) to establish it as a leading supplier of products that help ensure the safety of health care professionals, frontline workers, and communities around the world. Medicevo is focused on supplying rapidly available and sustainable medical supplies, including certified diagnostic/testing kits, medical consumables such as surgical masks and respirators, gloves, face shields, protective eyewear, coverall suits, and shoe coverings of specialized materials.
Medicevo will sell its products direct to consumer through its e-commerce site, starting with the Graphene Face Mask, made with graphene, a substance that has been scientifically proven to kill COVID-19 particles and other types of germs and infectious diseases. Built with four layers of protection for the wearer, Medicevo’s Graphene Face Mask has been evaluated by the American Society for Testing and Materials (ASTM) Standards for Medical Face Masks. Medicevo’s Graphene Face Mask provides a Bacterial Filtration Efficiency (BFE) of 98%, higher than N95 respirators.
TPG’s scope of work will educate potential customers on Medicevo’s Graphene Face Mask’s differentiation, boost awareness of the graphene benefits against COVID-19 and leverage targeted paid content to drive awareness and adoption. The dedicated digital marketing program includes building a library of content assets to use across Medicevo's website and social platforms to help drive sales. The program will also create editorial media coverage through content creation, article creation, native ad promotion, PPC / Google ads, paid social, and editorial media relations.
Medicevo’s Graphene Face Mask uses a patented production process that implants graphene into the fabric of the mask directly, creating a microscopic sharp-edged netting. When a virus comes in contact with Medicevo’s Graphene Face Mask, the graphene netting slices through the virus particle, killing it. The masks are scientifically proven to kill COVID-19 particles and other types of infectious diseases, like the seasonal flu, which is key for disease control and prevention.
Medicevo is the exclusive distributor of the state-of-the-art Medicevo Graphene Face Mask in the United States and Canada.